171 related articles for article (PubMed ID: 35976425)
1. What treatments reduce kidney stone risk in patients with bowel disease?
Bianco J; Chu F; Bergsland K; Coe F; Worcester E; Prochaska M
Urolithiasis; 2022 Oct; 50(5):557-565. PubMed ID: 35976425
[TBL] [Abstract][Full Text] [Related]
2. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
[TBL] [Abstract][Full Text] [Related]
3. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
4. Clinical Effectiveness of Calcium Oxalate Stone Treatments.
Gutbrod J; Keys McKay CC; Coe L; Bergsland K; Coe F; Worcester E; Prochaska M
Am J Nephrol; 2022; 53(10):761-766. PubMed ID: 36412567
[TBL] [Abstract][Full Text] [Related]
5. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets.
Noori N; Honarkar E; Goldfarb DS; Kalantar-Zadeh K; Taheri M; Shakhssalim N; Parvin M; Basiri A
Am J Kidney Dis; 2014 Mar; 63(3):456-63. PubMed ID: 24560157
[TBL] [Abstract][Full Text] [Related]
6. Simple dietary advice targeting five urinary parameters reduces urinary supersaturation in idiopathic calcium oxalate stone formers.
Sromicki J; Hess B
Urolithiasis; 2020 Oct; 48(5):425-433. PubMed ID: 32524204
[TBL] [Abstract][Full Text] [Related]
7. Calcium oxalate supersaturation increases early after Roux-en-Y gastric bypass.
Agrawal V; Liu XJ; Campfield T; Romanelli J; Enrique Silva J; Braden GL
Surg Obes Relat Dis; 2014; 10(1):88-94. PubMed ID: 23953730
[TBL] [Abstract][Full Text] [Related]
8. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
[TBL] [Abstract][Full Text] [Related]
9. Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation.
Lieske JC; Tremaine WJ; De Simone C; O'Connor HM; Li X; Bergstralh EJ; Goldfarb DS
Kidney Int; 2010 Dec; 78(11):1178-85. PubMed ID: 20736987
[TBL] [Abstract][Full Text] [Related]
10. Use of a probiotic to decrease enteric hyperoxaluria.
Lieske JC; Goldfarb DS; De Simone C; Regnier C
Kidney Int; 2005 Sep; 68(3):1244-9. PubMed ID: 16105057
[TBL] [Abstract][Full Text] [Related]
11. Risk of nephrolithiasis, hyperoxaluria, and calcium oxalate supersaturation increased after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis.
Upala S; Jaruvongvanich V; Sanguankeo A
Surg Obes Relat Dis; 2016; 12(8):1513-1521. PubMed ID: 27396545
[TBL] [Abstract][Full Text] [Related]
12. 24-Hour Urine Calcium Oxalate Supersaturation Risk Correlates with Computerized Tomography Volumetric Calcium Oxalate Stone Growth.
Yuzhakov S; Steadman SD; Otto BJ; Bird VG; Canales BK
J Urol; 2021 Dec; 206(6):1438-1444. PubMed ID: 34288713
[TBL] [Abstract][Full Text] [Related]
13. [Urinary calcium oxalate supersaturation beyond nephrolithiasis. Relationship with tubulointerstitial damage].
Toblli JE; Angerosa M; Stella I; Ferder L; Inserra F
Medicina (B Aires); 2003; 63(2):97-104. PubMed ID: 12793076
[TBL] [Abstract][Full Text] [Related]
14. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
[TBL] [Abstract][Full Text] [Related]
15. Subsequent urinary stone events are predicted by the magnitude of urinary oxalate excretion in enteric hyperoxaluria.
D'Costa MR; Kausz AT; Carroll KJ; Ingimarsson JP; Enders FT; Mara KC; Mehta RA; Lieske JC
Nephrol Dial Transplant; 2021 Dec; 36(12):2208-2215. PubMed ID: 33367720
[TBL] [Abstract][Full Text] [Related]
16. Intestinal Oxalate Absorption, Enteric Hyperoxaluria, and Risk of Urinary Stone Formation in Patients with Crohn's Disease.
Siener R; Ernsten C; Speller J; Scheurlen C; Sauerbruch T; Hesse A
Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257157
[TBL] [Abstract][Full Text] [Related]
17. Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease.
Evan AP; Lingeman JE; Worcester EM; Bledsoe SB; Sommer AJ; Williams JC; Krambeck AE; Philips CL; Coe FL
Kidney Int; 2010 Aug; 78(3):310-7. PubMed ID: 20428098
[TBL] [Abstract][Full Text] [Related]
18. Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis.
Schwille PO; Schmiedl A; Herrmann U; Fan J; Gottlieb D; Manoharan M; Wipplinger J
Urol Res; 1999 Apr; 27(2):117-26. PubMed ID: 10424393
[TBL] [Abstract][Full Text] [Related]
19. Etiology, urine metabolic risk factors, and urine oxalate patterns in patients with significant hyperoxaluria and recurrent nephrolithiasis.
Moore JP; Mauler DJ; Narang GL; Stern KL; Humphreys MR; Keddis MT
Int Urol Nephrol; 2022 Nov; 54(11):2819-2825. PubMed ID: 35917078
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Metabolic Correlates of Calcium Oxalate Stone Subtypes: Implications for Etiology and Management.
Bamberger JN; Blum KA; Kan KM; Parkhomenko E; Gallante B; Gupta M
J Endourol; 2019 Sep; 33(9):755-760. PubMed ID: 31154910
[No Abstract] [Full Text] [Related]
[Next] [New Search]
